Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    LumiraDx Limited (LMDXW)

    Price:

    0.00 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    LMDXW
    Name
    LumiraDx Limited
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    Price
    0.004
    Market Cap
    5.102M
    Enterprise value
    555.258M
    Currency
    USD
    Ceo
    Veronique Ameye EMBA,
    Full Time Employees
    1210
    Ipo Date
    2021-09-29
    City
    London
    Address
    3 More London Riverside

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Syneos Health, Inc.

    VALUE SCORE:

    0

    Symbol
    SYNH
    Market Cap
    4.458B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    2nd position

    GRAIL, Inc.

    VALUE SCORE:

    9

    Symbol
    GRAL
    Market Cap
    1.234B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare

    The best

    Medpace Holdings, Inc.

    VALUE SCORE:

    9

    Symbol
    MEDP
    Market Cap
    13.025B
    Industry
    Medical - Diagnostics & Research
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.010
    P/S
    0.020
    P/B
    -0.043
    Debt/Equity
    -3.818
    EV/FCF
    -1.637
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    1.204
    Earnings yield
    -99.470
    Debt/assets
    0.910
    FUNDAMENTALS
    Net debt/ebidta
    -1.101
    Interest coverage
    -2.389
    Research And Developement To Revenue
    0.557
    Intangile to total assets
    0.073
    Capex to operating cash flow
    -0.154
    Capex to revenue
    0.098
    Capex to depreciation
    0.751
    Return on tangible assets
    -1.099
    Debt to market cap
    78.644
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    -0.000
    P/CF
    -0.028
    P/FCF
    -0.027
    RoA %
    -101.855
    RoIC %
    -90.553
    Gross Profit Margin %
    -13.872
    Quick Ratio
    1.928
    Current Ratio
    2.908
    Net Profit Margin %
    -176.518
    Net-Net
    -1.249
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.663
    Revenue per share
    0.902
    Net income per share
    -1.592
    Operating cash flow per share
    -0.574
    Free cash flow per share
    -0.663
    Cash per share
    0.354
    Book value per share
    -0.373
    Tangible book value per share
    -0.487
    Shareholders equity per share
    -0.372
    Interest debt per share
    1.898
    TECHNICAL
    52 weeks high
    0.006
    52 weeks low
    0.004
    Current trading session High
    0.006
    Current trading session Low
    0.004
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.686
    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.010

    No data to display

    logo

    Country
    LU
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0.046

    No data to display

    logo

    Country
    GB
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -16.528

    No data to display

    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.540

    No data to display

    DESCRIPTION

    LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.

    NEWS